SOURCE: Triplefin LLC

Triplefin LLC

Triplefin LLC

November 27, 2012 08:00 ET

Triplefin Acquires Interest in Specialty Pharmacy Nursing Network (SPNN)

CINCINNATI, OH--(Marketwire - Nov 27, 2012) - Triplefin, an industry leader providing pharmaceutical marketing support solutions, including patient reimbursement support services; patient assistance programs; traditional and alternative Rx sampling; and patient adherence solutions, announced its acquisition of a minority interest in Specialty Pharmacy Nursing Network (SPNN) to complement its reimbursement hub model.

"The acquisition demonstrates Triplefin's commitment to helping facilitate patient access to therapy. As we continue to expand our suite of reimbursement and patient support services, SPNN plays a critical role in personalized patient care," said Greg LaLonde, President and CEO of Triplefin.

SPNN provides both clinical and non-clinical services to specialty pharmacies as well as pharmaceutical, biotech, and medical device manufacturers. SPNN serves as an extension to Triplefin's solutions and services by providing access, adherence and compliance programs specifically designed for hi-touch patient populations.

"Our number one focus is to provide patients with access to the therapies that they require in a timely manner without compromising patient care," said Cherylann Gregory, Founder and President of SPNN. "Because our service model was developed by highly experienced infusion nurses, the care of patients is our number one priority. Our flexible customized solutions can be tailored to integrate with Triplefin's current service offerings or we can develop a comprehensive access solution to meet their needs."

SPNN customized programs include:

  • Nationwide Infusion Nursing Services
  • Self-Administration and Injection Training
  • Health/Outcome Management Solutions
  • Reimbursement Support Programs
  • Complete Patient Service Center Solutions
  • Patient Assistance Programs
  • Clinical Call Center Solutions
  • Hi-touch Therapy Management

Triplefin is recognized as the premier provider of pharmaceutical marketing support solutions. For more than 30 years, Triplefin has continually helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients' hands… and keep them there throughout treatment. Today, more than 40 pharmaceutical manufacturing companies (including 14 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with Triplefin's solutions.

About Triplefin
Triplefin, founded in 1981, is privately owned and headquartered in Cincinnati, Ohio. Triplefin provides strategic, customized brand support and growth solutions to leading pharmaceutical manufacturing companies. Our mission is to connect patients, providers, pharmacies, and payers to improve outcomes and to remove brand challenges with access, acquisition, and adherence.

A highly experienced team with an in-depth understanding of the pharmaceutical marketing industry is standing by to help brand managers grow their brands. For more information about Triplefin's Solutions, please visit or connect with LeTicia Hallstead, Executive Vice President, Business Development at 855-TRPLFIN (855-877-5346).